Suppr超能文献

2 型脱碘酶 Thr92Ala 多态性与衰老与垂体对甲状腺激素敏感性降低有关。

Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.

机构信息

Department of Clinical Medicine and Surgery, University of Naples "Federico II," Naples, Italy.

Department of Public Health, University of Naples "Federico II," Naples, Italy.

出版信息

Thyroid. 2023 Mar;33(3):294-300. doi: 10.1089/thy.2022.0472. Epub 2023 Feb 13.

Abstract

The DIO2 Thr92Ala polymorphism (rs225014), which occurs in about 15-30% of Caucasian people, determines a less efficient type 2 deiodinase (D2) enzyme. The aim of this study was to determine the impact of DIO2 Thr92Ala polymorphism on the serum thyrotropin (TSH) levels in thyroidectomized patients with hypothyroidism and to evaluate whether TSH levels and aging could be related, at pituitary level, to D2 activity. This prospective study was performed on 145 thyroid cancer patients, treated with total thyroidectomy, and undergoing radioiodine treatment after 3 weeks of levothyroxine (LT4) withdrawal. A mouse model has been used to determine D2 protein and mRNA levels in pituitary during aging. Genetic analysis identified DIO2 Thr92Ala polymorphism in 56% of participants: 64/145 (44%) patients were homozygous wild type (WT) (Thr/Thr), 64 (44%) heterozygous (Thr/Ala), and 17 (12%) homozygous mutant (Ala/Ala). A significant negative relationship was observed between aging and the rise in serum TSH levels during LT4 withdrawal. However, this negative correlation found in WT was reduced in heterozygous and lost in mutant homozygous patients (Thr/Thr  = -0.45,  = 0.0002, 95% confidence interval [CI] -0.63 to -0.23; Ala/Thr  = -0.39,  = 0.0012, CI -0.60 to -0.67; and Ala/Ala  = -0.30,  = 0.2347; CI -0.70 to 0.20). Accordingly, when we compared the TSH measured in each patient to its theoretical value predicted from age, the TSH did not reach its putative target in 47% of WT patients, in 70% of Ala/Thr, and 76% of Ala/Ala carrying patients ( = 0.0036). This difference was lost in individuals older than 60 years, suggesting a decline of D2 associated with aging. The hypothesis that the pituitary D2 decreases with age was confirmed by the evidence that D2 mRNA and protein levels were lower in pituitary from old versus young mice. An age-related decline in TSH production in response to hypothyroidism was correlated with decreased D2 levels in pituitary. The presence of 2 homozygous Ala/Ala polymorphism was associated with a reduced level of TSH secretion in response to hypothyroidism, indicating a decreased pituitary sensitivity to serum thyroxine variation (Institutional Research Ethics board approval number no. 433/21).

摘要

DIO2 Thr92Ala 多态性(rs225014)发生在约 15-30%的白种人中,决定了一种效率较低的 2 型脱碘酶(D2)酶。本研究旨在确定 DIO2 Thr92Ala 多态性对甲状腺切除术后甲状腺功能减退症患者血清促甲状腺激素(TSH)水平的影响,并评估 TSH 水平和衰老是否与垂体水平的 D2 活性有关。这项前瞻性研究共纳入 145 例甲状腺癌患者,均接受甲状腺全切除术,并在停用左旋甲状腺素(LT4)3 周后进行放射性碘治疗。已使用小鼠模型来确定衰老过程中垂体中的 D2 蛋白和 mRNA 水平。遗传分析在 56%的参与者中确定了 DIO2 Thr92Ala 多态性:64/145(44%)患者为纯合野生型(Thr/Thr),64(44%)为杂合子(Thr/Ala),17(12%)为纯合突变型(Ala/Ala)。在 LT4 停药期间,随着衰老,血清 TSH 水平的升高呈显著负相关。然而,在 WT 中发现的这种负相关在杂合子中减少,在突变纯合子患者中消失(Thr/Thr = -0.45,= 0.0002,95%置信区间 [CI] -0.63 至 -0.23;Ala/Thr = -0.39,= 0.0012,CI -0.60 至 -0.67;和 Ala/Ala = -0.30,= 0.2347;CI -0.70 至 0.20)。因此,当我们将每个患者测量的 TSH 与其从年龄预测的理论值进行比较时,在 47%的 WT 患者、70%的 Ala/Thr 患者和 76%的 Ala/Ala 患者中,TSH 并未达到其假定的目标(= 0.0036)。在年龄大于 60 岁的个体中,这种差异消失,这表明与衰老相关的 D2 减少。D2 mRNA 和蛋白水平在老年与年轻小鼠的垂体中较低的证据证实了与年龄相关的 D2 随年龄下降的假设。甲状腺功能减退症时 TSH 产生的与年龄相关的下降与垂体中 D2 水平的降低有关。存在 2 个纯合 Ala/Ala 多态性与甲状腺功能减退症时 TSH 分泌减少有关,这表明垂体对血清甲状腺素变化的敏感性降低(机构研究伦理委员会批准编号为 no.433/21)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验